GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: The Laryngoscope, Wiley, Vol. 131, No. 6 ( 2021-06), p. 1392-1397
    Abstract: An increasing number of treatment modalities for lymphatic malformations are being described, complicating therapeutic decisions. Understanding lymphatic malformation natural history is essential. We describe management of head and neck lymphatic malformations where decisions primarily addressed lesion‐induced functional compromise (ie, breathing, swallowing) to identify factors associated with invasive treatment and active observation. We hypothesize that non‐function threatening malformations can be observed. Study Design Retrospective case series. Methods Retrospective case series of consecutive head and neck lymphatic malformation patients (2000–2017) with over 2 years of follow‐up. Patient characteristics were summarized and associations with invasive treatment (surgery or sclerotherapy) tested using Fisher's exact. In observed patients, factors associated with spontaneous regression were assessed with Fisher's exact test. Results Of 191 patients, 101 (53%) were male, 97 (51%) Caucasian, and 98 (51.3%) younger than 3 months. Malformations were de Serres I–III 167 (87%), or IV–V 24 (12%), and commonly located in the neck (101, 53%), or oral cavity (36, 19%). Initial treatments included observation (65, 34%) or invasive treatments such as primary surgery (80, 42%), staged surgery (25, 13%), or primary sclerotherapy (9, 5%). Of 65 initially observed malformations, 8 (12%) subsequently had invasive treatment, 36 (58%) had spontaneous regression, and 21 (32%) elected for no invasive therapy. Spontaneous regression was associated with location in the lateral neck ( P = .003) and macrocystic malformations ( P = .017). Conclusion Head and neck lymphatic malformation treatment selection can be individualized after stratifying by stage, presence of functional compromise, and consideration of natural history. Recognizing the spectrum of severity is essential in evaluating efficacy of emerging treatments, as selected malformations may respond to observation. Level of Evidence 4 Laryngoscope , 131:1392–1397, 2021
    Type of Medium: Online Resource
    ISSN: 0023-852X , 1531-4995
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2021
    detail.hit.zdb_id: 2026089-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: The Laryngoscope, Wiley, Vol. 133, No. 4 ( 2023-04), p. 956-962
    Abstract: Large (De Serres stage [IV–V]) head and neck lymphatic malformations (HNLMs) often have multiple, high‐risk, invasive treatments (ITs) to address functional compromise. Logically reducing HNLM ITs should reduce treatment risk. We tested whether delaying HNLM ITs reduces total IT number. Materials Consecutive HNLM patients ( n  = 199) between 2010 and 2017, aged 0–18 years. Methods ITs (surgery or sclerotherapy) were offered for persistent or dysfunction causing HNLMs. Treatment effectiveness categorized by IT number: optimal (0–1), acceptable (2–5), or suboptimal ( 〉 5). Clinical data were summarized, and outcome associations tested ( χ 2 ). Relative risk (RR) with a Poisson working model tested whether HNLM observation or IT delay ( 〉 6 months post‐diagnosis) predicts treatment success (i.e., ≤1 IT). Results Median age at HNLM diagnosis was 1.3 months (interquartile range [IQR] 0–45 m) with 107/199(54%) male. HNLM were stage I–III (174 [88%] ), IV–V (25 [13%]). Initial treatment was observation (70 [35%] ), invasive (129 [65%]). Treatment outcomes were optimal (137 [69%] ), acceptable (36 [18%]), and suboptimal (26 [13%] ). Suboptimal outcome associations: EXIT procedure, stage IV–V, oral location, and tracheotomy ( p   〈  0.001). Stage I–III HNLMs were initially observed compared with stage I–III having ITs within 6 months of HNLM diagnosis, had a 82% lower relative treatment failure risk ([i.e., 〉 1 IT], RR = 0.09, 95% CI 0.02–0.36, p   〈  0.001). Stage I–III HNLMs with non‐delayed ITs had reduced treatment failure risk compared with IV–V (RR = 0.47, 95% CI 0.33–0.66, p   〈  0.001). Conclusion Observation and delayed IT in stage I–III HNLM (“Grade 1”) is safe and reduces IT (i.e., ≤1 IT). Stage IV–V HNLMs (“Grade 2”) with early IT have a greater risk of multiple ITs. Level of Evidence 4 Laryngoscope , 133:956–962, 2023
    Type of Medium: Online Resource
    ISSN: 0023-852X , 1531-4995
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2023
    detail.hit.zdb_id: 2026089-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Otolaryngology–Head and Neck Surgery, Wiley, Vol. 163, No. 2 ( 2020-08), p. 221-231
    Abstract: To describe the Trach Safe Initiative and assess its impact on unanticipated tracheostomy‐related mortality in outpatient tracheostomy‐dependent children (TDC). Methods An interdisciplinary team including parents and providers designed the initiative with quality improvement methods. Three practice changes were prioritized: (1) surveillance airway endoscopy prior to hospital discharge from tracheostomy placement, (2) education for community‐based nurses on TDC‐focused emergency airway management, and (3) routine assessment of airway events for TDC in clinic. The primary outcome was annual unanticipated mortality after hospital discharge from tracheostomy placement before and after the initiative. Results In the 5 years before and after the initiative, 131 children and 155 children underwent tracheostomy placement, respectively. At the end of the study period, the institution sustained Trach Safe practices: (1) surveillance bronchoscopies increased from 104 to 429 bronchoscopies, (2) the course trained 209 community‐based nurses, and (3) the survey was used in 488 home ventilator clinic visits to identify near‐miss airway events. Prior to the initiative, 9 deaths were unanticipated. After Trach Safe implementation, 1 death was unanticipated. Control chart analysis demonstrates significant special‐cause variation in reduced unanticipated mortality. Discussion We describe a system shift in reduced unanticipated mortality for TDC through 3 major practice changes of the Trach Safe Initiative. Implication for Practice Death in a child with a tracheostomy tube at home may represent modifiable tracheostomy‐related airway events. Using Trach Safe practices, we address multiple facets to improve safety of TDC out of the hospital.
    Type of Medium: Online Resource
    ISSN: 0194-5998 , 1097-6817
    Language: English
    Publisher: Wiley
    Publication Date: 2020
    detail.hit.zdb_id: 2008453-5
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: International Journal of Pediatric Otorhinolaryngology, Elsevier BV, Vol. 151 ( 2021-12), p. 110869-
    Type of Medium: Online Resource
    ISSN: 0165-5876
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2021
    detail.hit.zdb_id: 2224872-9
    detail.hit.zdb_id: 2009657-4
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...